Virso 400 mg Tablets

Product Description

Uses of Virso 400 mg Tab 28s:

Virso 400 mg Tablet is a prescription medicine used with other antiviral medicines to treat chronic (lasting a long time) hepatitis C (Hep C) infection in adults.

Side Effects of Virso 400 mg Tablets:

For Virso 400 mg Tablets used in combination with ribavirin they include tiredness and headache and for Virso Tablets used in combination with peginterferon alfa and ribavirin they include the additional side effects of nausea, difficulty sleeping, and low red blood cell count.

Virso 400 mg Tablet exporters and suppliers

Drug Interactions of Virso 400 mg Tablets 28s:

If you have: liver problems other than hepatitis C infection; had a liver transplant; severe kidney problems or are on dialysis; HIV; any other medical condition; or if you are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will take Virso 400mg or breastfeed. You should not do both. If you take amiodarone Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how Virso 400 mg tablets works.
Contraindications of Virso 400mg Tab 28s:
When used in combination with peginterferon alfa/ribavirin or ribavirin alone, all contraindications to peginterferon alfa and/or ribavirin also apply to Virso 400mg Tablets combination therapy.
Mechanism of Action of Virso 400mg Tab 28s:

Virso 400 mg Tablets inhibits the RNA polymerase that the hepatitis C virus uses to replicate its RNA. It was discovered at Pharmasset and developed by Gilead Sciences.

Special Precautions for Virso 400 mg Tablets 28s:

Bradycardia with Amiodarone: Patients with amiodarone and Virso 400 mg Tablets in combination with another direct-acting antiviral drug (DAA) may experience severe symptomatic bradycardia Especially in patients treated with beta blockers or patients with cardiac complications and/or advanced liver disease. Combination of amiodarone with Virso Tablets and another DAA is not recommended. Cardiac monitoring is recommended in patients without alternative treatment options. Pregnancy: Ribavirin may cause birth defects and fetal death, and animal studies have shown that interferon has a sputum effect; avoiding pregnancy in female patients and female partners of male patients. Before starting treatment, patients must undergo a negative pregnancy test using at least 2 effective methods of contraception and a monthly pregnancy test.